Background: Medtronic Micra VR and Abbott Aveir VR are two single-chamber ventricular leadless pacemakers (L-PMs) currently available in clinical practice. They differ in their design, fixation mechanism (tine-based fixation for Micra VR, screw-in helix fixation for Aveir VR), and implantation technique. Little comparative safety data are available for these LPMs.
Objective: To compare the rate of acute procedure-related complications between patients undergoing Aveir VR versus Micra VR implantation.
Methods: A prospective, multicentre, observational registry enrolled consecutive patients who underwent Aveir VR or Micra VR implantation. The rate and nature of device-related complications at 30-day follow-up were analyzed and compared between the two groups. Individual 1:1 propensity matching of baseline characteristics was performed.
Results: A total of 1,141 patients (75.9±14.8 years, 60.2% male) were enrolled: 211 Aveir VR, and 930 Micra VR. Propensity matching yielded 189 matched pairs. In the matched cohort, the risk of device-related complications at 30 days of follow-up of the two L-PMs was similar (2.1 vs. 2.1%; p=1.000). Device migration (1.6 vs. 0.5%; p=0.315) and vascular complications (0.5 vs. 1.1%; p=0.562) were the most frequent complications with no significant differences between the two groups. Cardiac perforation was rare (1 case in the Micra VR group, no cases in the Aveir VR group).
Conclusions: The risk of acute device-related complications associated with Aveir VR and Micra VR L-PMs implantation was similar. These findings suggest that, despite differences in design, fixation mechanism and implantation technique, these two devices appear to have a similar short-term safety profile.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.hrthm.2025.03.1881 | DOI Listing |
Heart Rhythm
March 2025
Ospedale Giovanni Paolo II, ASP di Ragusa, Ragusa, Italy.
Background: Medtronic Micra VR and Abbott Aveir VR are two single-chamber ventricular leadless pacemakers (L-PMs) currently available in clinical practice. They differ in their design, fixation mechanism (tine-based fixation for Micra VR, screw-in helix fixation for Aveir VR), and implantation technique. Little comparative safety data are available for these LPMs.
View Article and Find Full Text PDFIntern Med J
March 2025
Department of Cardiology, The Prince Charles Hospital, Brisbane, Queensland, Australia.
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) has become an established alternative to overcome conventional transvenous ICD (TV-ICD) lead-related complications.
Aims: To describe the long-term outcomes of S-ICD implantation at a single Australian institution.
Methods: We retrospectively reviewed the clinical outcomes of consecutive patients who underwent S-ICD implantation from 2015 to 2019.
J Saudi Heart Assoc
February 2025
Heart Centre, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
The totality of evidence suggests that there remains a significant disparity in the use of left ventricular assist devices (LVADs) and heart transplantation (HT) in women. This disparity persists even after accounting for differences in baseline characteristics, comorbidities, and cardiovascular risk factors between men and women undergoing LVAD implantation as a bridge to HT. Generally, women are less likely to undergo HT, leading to a higher mortality rate in women on the HT waiting list.
View Article and Find Full Text PDFClin Biomech (Bristol)
March 2025
Sint Maartenskliniek, Hengstdal 3, 6574 NA Ubbergen, the Netherlands.
Background: A previous randomized controlled trial showed higher tibial migration and more device-related complications in bicruciate-retaining compared to cruciate-retaining total knee arthroplasty, raising concerns about long-term implant stability and prompting this follow-up study to assess migration patterns and clinical outcomes up to 7.5 years postoperatively.
Methods: In this follow-up study, the bicruciate-retaining group from an initial single-centre randomized controlled trial was monitored at 5 and 7.
Heart Rhythm
March 2025
University Health Network Toronto, Peter Munk Cardiac Centre, Toronto Adult Congenital Heart Disease Program, and University of Toronto, Toronto, Ontario, Canada. Electronic address:
Background: Risk scores designed to predict adverse events (AE) including sudden death and ventricular arrhythmias can guide heightened surveillance and defibrillator (ICD) implantation. Variability in risk stratification derived from differing scores and guidelines has not been examined in repaired tetralogy of Fallot (rTOF).
Objectives: To determine the consistency in AE risk prediction across published scoring systems in rTOF patients without a secondary prevention ICD indication.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!